Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 5,576 | 5,716 | 3,615 | 6,662 | 5,503 |
| Cost of Goods | 1,496 | 1,680 | 2,191 | 2,477 | 2,307 |
| Gross Profit | 4,080 | 4,036 | 1,424 | 4,185 | 3,196 |
| Operating Expenses | 7,322 | 7,473 | 5,665 | 8,662 | 8,629 |
| Operating Income | -2,746 | -2,757 | -4,050 | -4,000 | -5,126 |
| Interest Expense | 0 | 185 | 304 | 341 | 372 |
| Other Income | -9,126 | 4,226 | -113 | 3,542 | 1,689 |
| Pre-tax Income | -11,872 | 1,284 | -4,467 | -799 | -3,809 |
| Net Income Continuous | -11,872 | 1,284 | -4,467 | -799 | -3,809 |
| Net Income | $-11,872 | $1,284 | $-4,467 | $-799 | $-3,809 |
| EPS Basic Total Ops | -1.73 | 0.28 | 1.62 | -0.27 | -2.15 |
| EPS Basic Continuous Ops | -1.73 | 0.28 | 1.63 | -0.27 | -2.15 |
| EPS Diluted Total Ops | -1.73 | 0.28 | 1.62 | -0.27 | -2.15 |
| EPS Diluted Continuous Ops | -1.73 | 0.28 | 1.63 | -0.27 | -2.15 |
| EPS Diluted Before Non-Recurring Items | -0.68 | -0.63 | -1.46 | -1.47 | -3.10 |
| EBITDA(a) | $-2,644 | $-2,519 | $-3,725 | $-3,650 | $-4,752 |